Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| UNITED THERAPEUTICS Corp | FORM 8-K | 13 Jan 2025 |
| CONMED Corp | 8-K | 13 Jan 2025 |
| ICHOR HOLDINGS, LTD. | 8-K | 13 Jan 2025 |
| Fossil Group, Inc. | 8-K | 13 Jan 2025 |
| Genprex, Inc. | FORM 8-K | 13 Jan 2025 |
| GLYCOMIMETICS INC | FORM 8-K | 13 Jan 2025 |
| Mission Produce, Inc. | 8-K | 13 Jan 2025 |
| DYNAVAX TECHNOLOGIES CORP | 8-K | 13 Jan 2025 |
| Cytosorbents Corp | FORM 8-K | 13 Jan 2025 |
| RECURSION PHARMACEUTICALS, INC. | 8-K | 13 Jan 2025 |
| 10x Genomics, Inc. | 8-K | 13 Jan 2025 |
| SI-BONE, Inc. | 8-K | 13 Jan 2025 |
| Apellis Pharmaceuticals, Inc. | 8-K | 13 Jan 2025 |
| Sana Biotechnology, Inc. | 8-K | 13 Jan 2025 |
| Editas Medicine, Inc. | 8-K | 13 Jan 2025 |
| Ondas Holdings Inc. | CURRENT REPORT | 13 Jan 2025 |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | 8-K | 13 Jan 2025 |
| GoodRx Holdings, Inc. | 8-K | 13 Jan 2025 |
| Design Therapeutics, Inc. | 8-K | 13 Jan 2025 |
| Alkermes plc. | 8-K | 13 Jan 2025 |
